CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases.
Regulatory T cells (Tregs) have been shown to play an important role in maintaining peripheral immune homeostasis by suppressing autoreactive and allergen-specific T cells and turning off the immune response after the pathogen has been cleared. However, in certain situations Tregs can impair effective immunity to some pathogens and tumour cells. To review the role of Tregs in liver pathology and to assess the potential to enhance or inhibit their function as applied to the treatment of liver disease. The literature was reviewed using standard indexing terms and incorporating publications up to and including those published in 2007. Tregs are therapeutic targets for modulation in autoimmune disease and may provide new opportunities for application to human liver conditions.